Anglo American enters deal to power Peru copper mine by renewables

Globe Newswire

North American Molecular Diagnostics (MDx) Market Report 2021-2031

Forecasts by technology (polymerase chain reaction, field hybridization, isothermal technology for nucleic acid amplification, chips and microchips, mass spectrometry, sequencing, transcriptional mediated amplification, others), by application (oncology, pharmacogenomics, infectious diseases, genes neurological diseases, neurological diseases Cardiovascular diseases, microbiology, others), by product (instruments, reagents), test site (point of care, without prescription, central laboratories), by country (USA, Canada) PLUS Analysis of leading companies for MDx AND COVID-19 Recovery Scenarios, New York, April 15, 2021 (GLOBE NEWSWIRE) – announces the release of the North American Molecular Diagnostics (MDx) Market Report 2021-2031 – https: // www. utm_source = GNW Increasing spread of infectious diseases expected to grow in Augur market According to the CDC in the United States, nosocomial infections (HAI) account for more than 1.5 million infections and nearly 95,000 related deaths annually. Molecular diagnostics is crucial in the field of tests for infectious diseases, as it provides fast and successful results. Therefore, the growing prevalence of infectious diseases and hospital-acquired infections will fuel the molecular diagnostics market in the North American region from 2021 to 2031. What factors fuel the growth of the North American molecular diagnostic market? Population Centers – Increasing prevalence of targeted diseases such as genetic, CVD and neurological diseases – Introduction of technologically advanced products What factors limit growth? – High prices of molecular diagnostic tests – Existence of an ambiguous regulatory framework to hamper market growth Technological progress to stimulate market growth According to the analysis, advances in technology are expected to stimulate the growth of the molecular diagnostic industry in North America, as they provide greater accuracy and are cost-effective. The market is likely to be driven by the launch of MinION, an affordable and compact sequencer that supplies consumers to small peripheral laboratories and care centers. The high demand for non-prescription diagnostics is also expected to help grow the market in this area. In addition, some of the key factors such as advanced cancer diagnostic tests, combined with the growing demand for genetic testing, are expected to boost market growth by 2031. UNIQUE COVID-19 VARIATIONS – available only in this report are a special analysis of 4 different the scenario of a rebound of how the market will develop – no matter how COVID-19 affects the economy. How do prominent players strengthen their positions around the world? You should read this newly updated report if you are involved in this sector. Your report shows potential revenue up to 2031, assesses information, trends, opportunities and business prospects. Discover how to move forward Our 350+ page report provides 500+ tables and charts. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study allows you to estimate projected sales in the common market in North America and at the country level. See financial results, trends, opportunities and revenue forecasts. Many opportunities remain in this growing market for molecular diagnostics in North America. See how to use the opportunities. Forecasts until 2031 and other analyzes reveal the trade prospects. In addition to forecasting revenue by 2031, our new survey provides you with up-to-date results, growth rates and market shares. Find original analyzes, business prospects and development. Discover qualitative analyzes (including market dynamics, engines, opportunities, constraints and challenges), SWOT analysis, PEST analysis, Porter analysis, product profiles and commercial developments. Discover sales forecasts for the North American market and Technology submarkets. Polymerase chain reaction – Multiplex PCR – Other PCR. In Situ Hybridization. Isothermal technology for nucleic acid amplification. Chips and microchips. Mass spectrometry. Consistency. Transcription-mediated amplification. Other Application. Oncology – breast cancer – prostate cancer – colorectal cancer – cervical cancer – kidney cancer – liver cancer – blood cancer – lung cancer – another cancer. Pharmacogenomics. Infectious diseases – methicillin-resistant staphylococcus aureus – Clostridium Difficile – vancomycin-resistant enterococci – carbapenem-resistant bacteria – influenza – respiratory syncytial virus – candida – tuberculosis and drug-resistant TBA – meningitis-gastric-gastric-gastrointestinal – Hepatitis B- Other infectious diseases. Genetic testing – Newborn screening – Prognostic and asymptomatic testing – Other genetic testing. Neurological disease. Cardiovascular diseases. Microbiology. Other Product. Tools. Reagents Test location. Point of care. Above the counter. Central Laboratories In addition to revenue forecasts for the overall market and segments in North America, you will also find revenue forecasts by country by segment: US Molecular Diagnostics Market – Technology Revenue Estimates – Application Revenue Estimates – Revenue Estimates Products – Revenue estimates by test location. Canada Molecular Diagnostics Market – Technology Revenue Estimates – Application Revenue Estimates – Product Revenue Estimates – Test Site Revenue Estimates Leading Companies and Market Growth Potential Total revenues for the North American Molecular Diagnostics Market will exceed xx million dollars in 2021. We anticipate strong revenue growth by 2031. Our work identifies which organizations have the greatest potential. Discover their opportunities, progress and trade prospects by helping you stay ahead. Prospects for established companies and those who want to enter the market – including company profiles for 16 of the major companies involved in the molecular diagnostics market in North America. Some of the companies profiled in this report are Roche Diagnostics, Abbott, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Dako (Agilent Technologies), Danaher, FOUNDATION MEDICINE, INC., Genomic Health (Exact Sciences Corporation), Hologic, Inc., Illumina, Inc., HTG Molecular Diagnostics, Inc., Grifols, SA, QIAGEN, Siemens Healthcare GmbH and Sysmex Corporation. Key questions answered by this report :. What is the current market size for molecular diagnostics in North America? How much will this market cost from 2021 to 2031? What are the main drivers and constraints that will shape the North American molecular diagnostics market over the next ten years? What are the main market segments for molecular diagnostics in North America? How much will each of these segments cost for the period 2021 to 2031? How will the composition of the market change during this time and why? What factors will affect this industry and market in the next ten years? What are the largest national markets for molecular diagnostics in North America? What is their current status and how will they develop over the next ten years? What are their potential revenues by 2031? How will the market shares of the leading national markets change by 2031 and which geographical region will lead the market in 2031? Who are the leading companies and what are their activities, results, development and prospects? What are the main trends that will affect the North American molecular diagnostics market between 2021 and 2031? What are the main strengths, weaknesses, opportunities and threats to the market? How will the North American molecular diagnostics market develop over the forecast period, 2021 to 2031? How will the market shares of prominent national markets change from 2021 and which countries will lead the market in 2031, achieving the highest revenues and the fastest growth? Find quantitative and qualitative analyzes with independent forecasts. Receive information that only our report contains by being informed with this invaluable business intelligence. Information not found anywhere else With our new report title, you are less likely to lag behind in knowledge or miss opportunities. See how our work can be useful for your research, analysis and solutions. This study is designed for anyone who needs commercial analysis for the North American molecular diagnostics market and leading companies. You will find data, trends and forecasts. Read the full report: About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you can get all the market research you need – instantly, in one place. __________________________ CONTACT: Clare: [email protected] USA: (339) -368-6001 Intl: +1 339-368 -6001

Comments are closed.